Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renate Pichler

Showing results (111-120 of 196) with videos related to

Pageof 20
Sort By:
Urologia Internationalis|July 29, 2025
Acute kidney injury causes chronic kidney disease progression after partial nephrectomy: A retrospective study identifying patients at riskSebastian Kälble, Simon Udo Engelmann, Maximilian Haas, et al.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2025
Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortalityFlorian Moik, Angelika Terbuch, Ariane Sprakel, et al.
The Journal of Nutrition, Health & Aging|February 8, 2026
Sarcopenia and recurrence risk in high-risk non-muscle-invasive bladder cancer: a nonlinear modeling approachGerald Klinglmair, Maximilian Lutz, Tatia Telia, et al.
Clinical Genitourinary Cancer|June 13, 2025
Prognostic Role of Serum IL-6 Levels in Bladder Cancer Patients and Hints of its OriginSimon U Engelmann, Christoph Pickl, Maximilian Haas, et al.
Therapeutic Advances in Medical Oncology|November 25, 2022
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-upHannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, et al.
Clinical Genitourinary Cancer|June 26, 2019
Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS StudyManuela Schmidinger, Renate Pichler, Wolfgang Loidl, et al.
Journal of Clinical Medicine|May 11, 2024
Variation in Follow-Up after Radical Cystectomy for Bladder Cancer-An Inventory Roundtable and Literature ReviewRoberto Contieri, Renate Pichler, Francesco Del Giudice, et al.
Frontiers in Immunology|July 31, 2023
Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2Renate Pichler, Gabriel Diem, Hubert Hackl, et al.
Translational Oncology|September 3, 2025
Lipid metabolism of clear cell renal cell carcinoma predicts survival and affects intratumoral CD8 T cellsJakob Simeth, Simon Engelmann, Roman Mayr, et al.
Journal of Clinical Medicine|June 27, 2024
Perioperative Outcomes and Trends in Transurethral Resection of Bladder Tumors with Photodynamic Diagnosis: Results from the GeRmAn Nationwide Inpatient Data StudyNikolaos Pyrgidis, Marco Moschini, Lazaros Tzelves, et al.
Pageof 20

Showing results (111-120 of 196) with videos related to

Sort By:
Pageof 20
Urologia Internationalis|July 29, 2025
Acute kidney injury causes chronic kidney disease progression after partial nephrectomy: A retrospective study identifying patients at riskSebastian Kälble, Simon Udo Engelmann, Maximilian Haas, et al.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2025
Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortalityFlorian Moik, Angelika Terbuch, Ariane Sprakel, et al.
The Journal of Nutrition, Health & Aging|February 8, 2026
Sarcopenia and recurrence risk in high-risk non-muscle-invasive bladder cancer: a nonlinear modeling approachGerald Klinglmair, Maximilian Lutz, Tatia Telia, et al.
Clinical Genitourinary Cancer|June 13, 2025
Prognostic Role of Serum IL-6 Levels in Bladder Cancer Patients and Hints of its OriginSimon U Engelmann, Christoph Pickl, Maximilian Haas, et al.
Therapeutic Advances in Medical Oncology|November 25, 2022
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-upHannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, et al.
Clinical Genitourinary Cancer|June 26, 2019
Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS StudyManuela Schmidinger, Renate Pichler, Wolfgang Loidl, et al.
Journal of Clinical Medicine|May 11, 2024
Variation in Follow-Up after Radical Cystectomy for Bladder Cancer-An Inventory Roundtable and Literature ReviewRoberto Contieri, Renate Pichler, Francesco Del Giudice, et al.
Frontiers in Immunology|July 31, 2023
Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2Renate Pichler, Gabriel Diem, Hubert Hackl, et al.
Translational Oncology|September 3, 2025
Lipid metabolism of clear cell renal cell carcinoma predicts survival and affects intratumoral CD8 T cellsJakob Simeth, Simon Engelmann, Roman Mayr, et al.
Journal of Clinical Medicine|June 27, 2024
Perioperative Outcomes and Trends in Transurethral Resection of Bladder Tumors with Photodynamic Diagnosis: Results from the GeRmAn Nationwide Inpatient Data StudyNikolaos Pyrgidis, Marco Moschini, Lazaros Tzelves, et al.
Pageof 20